Section 152.33 — Violations.
152.33 VIOLATIONS. Subdivision 1. Intentional diversion; criminal penalty. In addition to any other applicable penalty in law, a manufacturer or an agent of a manufacturer who intentionally transfers medical cannabis to a person other than another registered manufacturer, a patient, a registered designated caregiver or, if listed on the registry verification, a parent, legal guardian, […]
Section 152.25 — Commissioner Duties.
152.25 COMMISSIONER DUTIES. Subdivision 1. Medical cannabis manufacturer registration. (a) The commissioner shall register two in-state manufacturers for the production of all medical cannabis within the state. A registration agreement between the commissioner and a manufacturer is nontransferable. The commissioner shall register new manufacturers or reregister the existing manufacturers by December 1 every two years, […]
Section 152.26 — Rulemaking.
152.26 RULEMAKING. (a) The commissioner may adopt rules to implement sections 152.22 to 152.37. Rules for which notice is published in the State Register before January 1, 2015, may be adopted using the process in section 14.389. (b) The commissioner may adopt or amend rules, using the procedure in section 14.386, paragraph (a), to implement […]
Section 152.261 — Rules; Adverse Incidents.
152.261 RULES; ADVERSE INCIDENTS. (a) The commissioner of health shall adopt rules to establish requirements for reporting incidents when individuals who are not authorized to possess medical cannabis under sections 152.22 to 152.37 are found in possession of medical cannabis. The rules must identify professionals required to report, the information they are required to report, […]
Section 152.21 — Thc Therapeutic Research Act.
152.21 THC THERAPEUTIC RESEARCH ACT. Subdivision 1. Findings and purpose. The legislature finds that scientific literature indicates promise for delta-9-tetrahydro-cannabinol (THC), the active component of marijuana, in alleviating certain side effects of cancer chemotherapy under strictly controlled medical circumstances. The legislature also finds that further research and strictly controlled experimentation regarding the therapeutic use of […]
Section 152.22 — Definitions.
152.22 DEFINITIONS. Subdivision 1. Applicability. For purposes of sections 152.22 to 152.37, the terms defined in this section have the meanings given them. Subd. 2. Commissioner. “Commissioner” means the commissioner of health. Subd. 3. Disqualifying felony offense. “Disqualifying felony offense” means a violation of a state or federal controlled substance law that is a felony […]
Section 152.23 — Limitations.
152.23 LIMITATIONS. (a) Nothing in sections 152.22 to 152.37 permits any person to engage in and does not prevent the imposition of any civil, criminal, or other penalties for: (1) undertaking any task under the influence of medical cannabis that would constitute negligence or professional malpractice; (2) possessing or engaging in the use of medical […]
Section 152.24 — Federally Approved Clinical Trials.
152.24 FEDERALLY APPROVED CLINICAL TRIALS. The commissioner may prohibit enrollment of a patient in the registry program if the patient is simultaneously enrolled in a federally approved clinical trial for the treatment of a qualifying medical condition with medical cannabis. The commissioner shall provide information to all patients enrolled in the registry program on the […]